Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 1,766 | 941 | 2,763 | 4,068 | 3,456 |
| Gross Profit | 1,766 | 941 | 2,763 | 4,068 | 3,456 |
| Operating Expenses | 13,888 | 8,705 | 19,636 | 123,745 | 28,982 |
| Operating Income | -12,122 | -7,764 | -16,873 | -119,677 | -25,526 |
| Other Income | 2,720 | 521 | 466 | 780 | 2,603 |
| Pre-tax Income | -9,402 | -7,243 | -16,407 | -118,897 | -22,923 |
| Income Tax | N/A | N/A | N/A | -765 | -19,082 |
| Net Income Continuous | -9,402 | -7,243 | -16,407 | -118,132 | -3,841 |
| Net Income | $-9,402 | $-7,243 | $-16,407 | $-118,132 | $-3,841 |
| EPS Basic Total Ops | 0.46 | -0.66 | -1.67 | -12.61 | -0.22 |
| EPS Basic Continuous Ops | 0.46 | -0.66 | -1.67 | -12.61 | -0.20 |
| EPS Diluted Total Ops | 0.46 | -0.66 | -1.67 | -12.61 | -0.22 |
| EPS Diluted Continuous Ops | 0.46 | -0.66 | -1.67 | -12.61 | -0.20 |
| EBITDA(a) | $-11,783 | $-7,595 | $-15,725 | $-27,604 | $-24,399 |